Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Rob, and I will be your conference operator today.
Maravai Lifesciences Holdings Inc. (MRVI)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 12 West Capital Management Joel Ramin | 2,568,770 | $35,988,468 | 3.09% | |
| 2. | Alyeska Investment Group Anand Parekh | 1,784,061 | $24,994,695 | +43% | 0.21% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,752,939 | $24,558,675 | -37% | 0.05% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 1,507,100 | $21,114,471 | +35% | 0.05% |
| 5. | AQR Capital Management Cliff Asness | 1,292,054 | $17,998,312 | -12% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $26.94 | 35,000 | Officer, Director | 35,000 | 2020-11-25 | Filing | |
| $27.00 | 20,000 | Director | 31,852 | 2020-11-24 | Filing | |
| $27.00 | 18,888 | Officer | 18,888 | 2020-11-24 | Filing | |
| $27.00 | 10,000 | Director | 21,852 | 2020-11-24 | Filing | |
| $27.00 | 18,000 | Director | 29,852 | 2020-11-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 21,681,033 | $303,751,272 | 15.01% | |
| 2. | 11,757,487 | $164,722,392 | 0.05% | |
| 3. | 10,559,197 | $147,934,350 | 0% | |
| 4. | 5,899,915 | $82,657,809 | 0% | |
| 5. | 3,890,477 | $54,505,000 | 0.03% |
News See All
Will Maravai LifeSciences Holdings (MRVI) be a Long-Term Compounder in Your Portfolio?
ClearBridge Investments, an investment management company, published its “ClearBridge Small Cap Value Strategy” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
13 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds
In this article, we will take a look at the 13 most undervalued healthcare stocks to buy according to hedge funds.
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the Fourth Quarter and Year-end 2022 Maravai LifeSciences Earnings Conference Call. Please note that this conference is being recorded.
11 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
In this article, we will take a look at the 11 most undervalued biotech stocks to buy according to hedge funds.
10 Best Medical Stocks Under $20
The healthcare industry has undergone a significant restructuring in the wake of the COVID-19 pandemic. There were multiple new healthcare trends in 2022 that have a lasting impact on the industry.
How Did Hedge Funds' Maravai LifeSciences Holdings, Inc. (MRVI) Bets Fare?
Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.
Here's What Makes Maravai LifeSciences (MRVI) A Great Investment Choice
ClearBridge Investments, an investment management firm, published its “Mid Cap Strategy” third quarter 2021 investor letter – a copy of which can be downloaded here.
Hedge Funds Are Coming Back To Maravai LifeSciences Holdings, Inc. (MRVI)
In this article we will analyze whether Maravai LifeSciences Holdings, Inc.
Is Maravai LifeSciences Holdings, Inc. (MRVI) Going to Burn These Hedge Funds?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Billionaire Hedge Funds
